Catching Vascular Issues Before They Become Post-Op Problems: A New Standard with VascuChek

Surgical site infections are a clear and present risk even for leading vascular programs. It’s estimated that there are more than 110,000 SSIs each year associated with inpatient surgeries, accounting for 20% of all healthcare-associated infections — and that number is growing annually.¹

Those infections pose a serious risk to not just the patient’s health, but the financial health of vascular programs, as well. Fortunately, Clinical Directors have a trusted partner to combat SSIs in the vascular operating room.

Remington’s VascuChek^® Doppler System proactively reduces the risk of infections in the OR through its cordless design and single-use probe with sheath, minimizing the risk of patients returning due to a post-surgical infection.

The Threat to Patient Outcomes

In a 2023 study, 90% of polled patients were at least slightly fearful about the risk of infection during hospitalization.² More than a quarter of them were “very” or “extremely” fearful of that risk, signaling a clear need for assurance from healthcare systems.

Unfortunately, those fears may be well founded. Surgical Site Infections after vascular surgery are a frequent nosocomial complication and an important cause of postoperative morbidity. Patients undergoing arterial interventions are at elevated risk of SSIs (overall incidence of 5% to 10%).³

Those infections carry severe risks for patient outcomes. Multiple studies have shown that SSIs are a major cause of complications including morbidity, extended hospitalization, and even death. Mortality is two to 11 times more likely for patients who contract an SSI,¹ a worst-case scenario that is far too close to reality for some vascular patients.

Don’t let infections define your vascular program’s success. In the face of rising SSI risks, Clinical Directors look to the VascuChek Doppler System to turn the tides and put patient safety first.

The Threat to Your Bottom Line

It’s not just patient trust that’s on the line when infection statistics surge; SSIs represent a major threat to a healthcare system’s bottom line, as well.

A 2025 report from the National Healthcare Safety Network discovered that SSIs are the single most costly healthcare-associated infection, costing hospitals an estimated $3.3 billion each year.¹

Part of that cost comes from extended patient stays or readmittance due to infection. The same report showed that SSIs extend a patient’s hospital stay by 9.7 days on average, racking up more than $20,000 per admission.¹

The costs of SSIs can’t be ignored, especially in a year when rising costs across the board pose a real threat to healthcare systems across the nation. Together, these factors make the VascuChek Doppler System a particularly sound investment for your vascular program’s financial health.

VascuChek: Purpose-Built to Combat SSIs

Considering their prevalence, it’s easy to assume that SSIs simply come with the territory of performing surgery. Not so; VascuChek is a simple solution to combat the risk of infection from vascular surgery.

The integrity of the sterile field is the foundation of the VascuChek Doppler System. VascuChek is the only FDA-cleared wireless, handheld Doppler device for evaluating intraoperative and subcutaneous blood flow in a sterile field during surgery.

Traditional Doppler machines are tethered to a power supply with cumbersome cords that present a threat to the sterility of the procedure. VascuChek’s wireless design removes cords from the equation entirely, removing one potential avenue of infection along with them.

The VascuChek system also offers single-use probes for use in the operating room. Those probes feature a patented antiseptic sheath that covers the entire transceiver, so vascular surgeons can evaluate blood flow without compromising the sterility of the procedure.

Together, these innovative features of the VascuChek Doppler System significantly reduce the risk of SSIs during a vascular procedure to ensure optimal patient outcomes and the financial success of your organization.

See Why Clinical Directors Choose VascuChek

Surgical site infections are a growing problem in operating rooms across the country, but they aren’t an inevitability. Forward-thinking Clinical Directors use the VascuChek Doppler System to help reduce the risk of SSIs and the multitude of post-op challenges they pose to patient outcomes and operational excellence.

With its innovative sterility-focused design, VascuChek is a sound investment in your OR’s infection control protocols. See for yourself the difference VascuChek can make with a personalized walkthrough.